Oddershede, J. K., Meklenborg, I. K., Bastholt, L., Guldbrandt, L. M., Schmidt, H., & Friis, R. B. (2025). Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility. Acta Oncologica, 64, 507–515. https://doi.org/10.2340/1651-226X.2025.42567